Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Why you can trust the stock market's current ‘buy' signals
02:29pm, Thursday, 12'th Oct 2023
The stock market, as measured by the S&P 500 Index SPX, has bounced off support, but it remains to be seen if this just an oversold rally or if it is the beginning of a new bullish trend. The support
ITGR or EW: Which Is the Better Value Stock Right Now?
12:47pm, Thursday, 21'st Sep 2023
Investors looking for stocks in the Medical - Instruments sector might want to consider either Integer (ITGR) or Edwards Lifesciences (EW). But which of these two stocks presents investors with the be
Here's Why You Should Invest in Edward Lifesciences (EW) Now
09:46am, Wednesday, 13'th Sep 2023
Investors continue to be optimistic about Edward Lifesciences (EW) on the strength of TAVR and a solid balance sheet.
ITGR vs. EW: Which Stock Is the Better Value Option?
12:47pm, Tuesday, 05'th Sep 2023
Investors interested in Medical - Instruments stocks are likely familiar with Integer (ITGR) and Edwards Lifesciences (EW). But which of these two stocks is more attractive to value investors?
Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains
12:26pm, Wednesday, 30'th Aug 2023
When you consider healthcare stocks, do you automatically think of pharmaceutical companies? Most people do.
Will Edwards Lifesciences Stock Recover To Its Pre-Inflation Shock Highs Of $130?
09:00am, Tuesday, 29'th Aug 2023
Investors still have concerns about a potential recession despite a steady decline in the inflation rate in response to the Fed's aggressive rate hike plan.
EDWARDS LIFESCIENCES TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE
08:10am, Monday, 28'th Aug 2023
IRVINE, Calif., Aug. 28, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the 2023 Wells Fargo Healthcare Conference on Thursday, Septemb
Edwards Lifesciences (EW) Rides on TAVR Amid Rise in Costs
12:47pm, Monday, 21'st Aug 2023
Edwards Lifesciences' (EW) Surgical Structural Heart business growth is driven by increased penetration of its premium RESILIA products across all regions.
Edwards Lifesciences: Rising Dominance In Structural Heart Disease
07:01am, Monday, 21'st Aug 2023
Edwards Lifesciences is the global leader in medical devices for structural heart disease and critical care monitoring. Their Transcatheter Aortic Valve Replacement technology dominates the market and
ITGR vs. EW: Which Stock Is the Better Value Option?
01:19pm, Friday, 18'th Aug 2023
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Integer (ITGR) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a
Here's Why You Should Invest in Edward Lifesciences (EW) Now
10:14am, Wednesday, 16'th Aug 2023
Investors continue to be optimistic about Edward Lifesciences (EW) on the strength of a solid foundation for innovative therapies.
3 MedTech Stocks Likely to Top Estimates This Earnings Season
09:45am, Thursday, 03'rd Aug 2023
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EYE, CAH and HSIC are poised ahead of their earnings releases.
You can still run with the stock market's bulls, but watch the exits
03:57pm, Thursday, 27'th Jul 2023
The stock market, as measured by the S&P 500 Index SPX, -0.64% ), has been moving upward. The U.S. benchmark index is essentially crawling up the higher “modified Bollinger Bands” (mBB), which is
Edwards Lifesciences (EW) Q2 Earnings Top Estimates, View Up
01:57pm, Thursday, 27'th Jul 2023
The growing adoption of the PASCAL Precision system in Europe and the United States and Edwards' premium products across all regions have driven Edwards Lifesciences' (EW) Q2 revenues.
Edwards Lifesciences Corporation (EW) Q2 2023 Earnings Call Transcript
08:43pm, Wednesday, 26'th Jul 2023
Edwards Lifesciences Corporation (NYSE:EW ) Q2 2023 Earnings Conference Call July 26, 2023 5:00 PM ET Company Participants Mark Wilterding - SVP, IR and Treasurer Bernard Zovighian - CEO Scott Ullem -
